Melinta Therapeutics Inc. (MLNT) Gained 16.77% or 0.81 To Price $5.64 On Thursday

Melinta Therapeutics Inc. (MLNT) gained 16.77% or 0.81 to $5.64. It is about 3.73 million shares traded, which is 782.7% compare to the average total volume 476780. The market cap of MLNT is $63.24 million. The year to date change is 6.21%. The 52 week price range is from $3.22 to $64.0. Price of MLNT have changed 0.00% during last week. It have changed -43.53% over last month, -31.43% over last 3 months, -77.93% over last 6 months and -92.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MLNT is 5.66. It is 0.35% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for MLNT is 18.32. It is 224.82% above current price. The 52-week High is 64.0. It is 1034.75% from the current price. The 52-week Low is 3.22. It is -42.91% from current price.

There are some statistics of MLNT. It is has market cap $63.24 million. The share outstanding is 11.21 million. The average volume is 476780. The percent of top 15 Institution holding is 83.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MLNT is -71.09%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MLNT is -40.57%.


Share this post